Contract award · 25 Feb 2026

NP90425 Faricimab (Vabysmo®)

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) awarded “Faricimab (Vabysmo®)” to Roche Products Ltd for £48.4m.

No competitionMedical equipment & pharmaceuticalsScotland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Value
£48,357,375
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Timeline
  1. Contract date25 Feb 2026
  2. Published24 Mar 2026Published 27 days after the contract date

Description

The Framework Agreement is for the supply of Faricimab (Vabysmo®) to NHSScotland. The Framework Agreement has been awarded as a single supplier framework Agreement to one (1) Framework Participant.

About the supplier

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
11 Feb 2026 Roche Products Ltd £48.4m

More from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

All contracts

More won by Roche Products Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview